Adjuvant 5‐Fluorouracil/leucovorin, capecitabine, and oxaliplatin‐related regimens for stage II/III colon cancer patients 66 years or older

Adjuvant 5‐Fluorouracil/leucovorin, capecitabine, and oxaliplatin‐related regimens for stage II/III colon cancer patients 66 years or older

Abstract Adjuvant chemotherapy of leucovorin‐modulated 5‐fluorouracil (5‐FU/LV), capecitabine, and adding oxaliplatin to 5‐FU/LV or capecitabine (FLOX/OX) have been standard regimens for high‐risk stage II or III colon cancer (CC). We aimed to evaluate their patterns of use, association with surviva...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Jones, Zhigang Duan, Thinh T. Nguyen, Sharon H. Giordano, Hui Zhao
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Online Access:https://doi.org/10.1002/cam4.5078
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items